TrialAmerican journal of hematology2021
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia.
Sangeetha Venugopal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it
TrialAmerican journal of hematology2021
Sangeetha Venugopal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.